Evidence map›Paper›PMID 36570802›Full record

ArticleBiomedical reports2023

Factors associated with disease severity of COVID‑19 in patients with type 2 diabetes mellitus.

Hermina Novida, Soebagijo Adi Soelistyo, Cupuwatie Cahyani, Nency Siagian, Usman Hadi, Agung Pranoto

Abstract read
In one paragraph

Article in Biomedical reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hermina NovidaDivision of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Soebagijo Adi SoelistyoDivision of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Cupuwatie CahyaniDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Nency SiagianDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Usman HadiDivision of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Agung PranotoDivision of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus causes a decline in immunological function, an increase in proinflammatory cytokines, and a prothrombotic state, thus providing risk factors for the severity of coronavirus disease 2019 (COVID-19) in patients with type 2 diabetes mellitus (T2DM). The aim of the present study was to analyze the risk factors associated with the severity of COVID-19 in patients with T2DM. A cross-sectional observational study was performed on 201 patients with T2DM from May 1 to August 31, 2020 and admitted to the isolation ward of Dr Soetomo General Hospital (Surabaya, Indonesia). The patients were divided into severe (108 cases; 53.7%) and non-severe (93 cases; 46.3%) groups, which were considered the dependent variables. Univariate and multivariate analysis was performed. The independent variables were age, sex, diabetes onset, chronic complications, presence of hypertension, randomized blood glucose, HbA1c, albumin, and neutrophil-lymphocyte ratio (NLR). A P-value <0.05 was considered to be statistically significant. The median age of the 201 subjects was 56 years, with 70.1% <60 years old, 52.7% male, 76.1% with diabetes onset <10 years, and 108 patients (53.7%) in severe condition. The results of the bivariate analysis revealed that diabetes onset >10 years (OR 2.5; P=0.011) was associated with severity of COVID-19 in patients with T2DM, however hypoalbumin (OR 1.93; P=0.054) was not associated with disease severity. Furthermore, multivariate analysis revealed that male sex (OR 2.07; P=0.042), age (≥60 years) (OR 2.92; P=0.008), HbA1c (≥8%) (OR 3.55; P=0.001), hypertension (OR 4.07; P=0.001), and an NLR ≥7.36 (OR 6.39; P=0.001) were associated with severe COVID-19. Collectively, it was revealed that increased NLR, hypertension, poor glycemic control, older age, and male sex were risk factors associated with the severity of COVID-19 among diabetic patients.

Indexed as

coronavirus disease 2019prognosisrisk factorssevere acute respiratory syndrome coronavirus 2type 2 diabetes mellitus

Identifiers

PMID36570802
PMCPMC9764056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.